Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8,-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the "clonidine-type".
D000316:Adrenergic alpha-Agonists; D000818:Animals; D000959:Antihypertensive Agents; D001381:Azepines / Q000494:pharmacology*; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000502:physiology; D003000:Clonidine / Q000494:pharmacology; D003655:Decerebrate State / Q000503:physiopathology; D004285:Dogs; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D009638:Norepinephrine / Q000502:physiology; D010080:Oxazoles / Q000494:pharmacology; D051381:Rats; D012018:Reflex / Q000187:drug effects; D013116:Spinal Cord / Q000502:physiology; D014628:Vagotomy
D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D001381:Azepines; D010080:Oxazoles; C015603:azepexole; D003000:Clonidine; D009638:Norepinephrine